维普中文期刊产品整合服务
652篇 您的检索式:作者名="Dispenzieri"
    题名 作者 年代 出处 被引量
1The clinical spectrum of Castleman’s disease显示文摘Angela Dispenzieri James O. Armitage Matt J. Loe Susan M. Geyer Jake Allred John K. Camoriano David M. Menke Dennis D. Weisenburger Kay Ristow Ahmet Dogan Thomas M. Habermann 2012Am. J. Hematol2012,,11:3
2Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013显示文摘Joseph R. Mikhael David Dingli Vivek Roy Craig B. Reeder Francis K. Buadi Suzanne R. Hayman Angela Dispenzieri Rafael Fonseca Taimur Sher Robert A. Kyle Yi Lin Stephen J. Russell Shaji Kumar P. Leif Bergsagel Steven R. Zeldenrust Nelson Leung Matthew T. D 2013Mayo Clinic Proceedings2013,,4:2
3Review of 1027 Patients With Newly Diagnosed Multiple Myeloma显示文摘Robert A. Kyle Morie A. Gertz Thomas E. Witzig John A. Lust Martha Q. Lacy Angela Dispenzieri Rafael Fonseca S. Vincent Rajkumar Janice R. Offord Dirk R. Larson Matthew E. Plevak Terry M. Therneau Philip R. Greipp 2003Mayo Clinic Proceedings2003,,1:2
4POEMS syndrome:definitions and long-term outcome显示文摘Dispenzieri A Kyle RA Lacy MQ 2003Blood2003,101,7:1
5POEMS syndrome:definitions and long-term outcome显示文摘Dispenzieri A Kyle RA Lacy MQ et ai 2003Blood2003,101,7:1
6POEMS syndrome:definition and long-term outcome显示文摘Dispenzieri A Kyle RA Lacy MQ 2003Blood2003,101,7:1
7POEMS syndrome: definitions and long-term outcome 显示文摘Dispenzieri A Kyle RA Lacy MQ 2003Blood2003,101,7:1
8POEMS syndrome:definition and long-term outcome显示文摘Dispenzieri A Kyle RA Lacy MQ 2003Blood2003,101,7:1
9Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma显示文摘Kumar S Witzig T E Dispenzieri A 0,,:1
10Chemotherapy induced insulin dependent diabetes mellitus显示文摘DISPENZIERI A C 1997Clinical Oneology1997,15,3:1
11Monoclonal gammopathy of undetermined significance, Waldenstrom macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment 显示文摘Rajkumar SV Dispenzieri A Kyle RA 2006Mayo Clin Proc2006,81,5:1
12Eligibility for hemato- poietic stem-cell transplantation for primary systemic amyloido- sis is a favorable prognostic factor for survival显示文摘Dispenzieri A Lacy MQ Kyle RA 2001J Clin Oncol2001,19,14:1
13Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma显示文摘Dispenzieri A Kyle R A Katzmann J A 2008Blood2008,111,2:1
14POEMS syndrome: definition and long-term outcome 显示文摘Dispenzieri A Kyle RA Lacy MA 2003Blood2003,101,7:1
15Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosis显示文摘Gertz M Lacy M Dispenzieri A 2008Leuk Lymphoma2008,49,1:1
16POEMS syndrome:definition and long-term outcome显示文摘Dispenzieri A Kyle R A Lacy M Q 2003Blood2003,101,1:1
17POEMS syndrome:Update on diagnosis,risk- stratification,and management显示文摘Dispenzieri A 2012Am J Hematol2012,87,8:1
18Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature显示文摘Dispenzieri A Moreno-Aspitia A Suarez GA 2004Blood2004,104,10:1
19POEMS syndrome: defini- tions and long-term outcome 显示文摘Dispenzieri A Kyle RA Lacy MQ 2003Blood2003,101,7:1
20New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes 显示文摘Palladini G Dispenzieri A Gertz MA 2012J Clin Oncol2012,30,36:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费